Prostate cancer. Technology versus biology
Open Access
- 15 July 1993
- Vol. 72 (2) , 305-309
- https://doi.org/10.1002/1097-0142(19930715)72:2<305::aid-cncr2820720202>3.0.co;2-i
Abstract
No abstract availableThis publication has 35 references indexed in Scilit:
- Prostate Specific Antigen after External Beam Radiotherapy for Prostatic Cancer: FollowupJournal of Urology, 1993
- Is Prostate Specific Antigen of Clinical Importance in Evaluating Outcome after Radical ProstatectomyJournal of Urology, 1993
- Large, Organ Confined, Impalpable Transition Zone Prostate Cancer: Association with Metastatic Levels of Prostate Specific AntigenJournal of Urology, 1993
- Conformal static field radiation therapy treatment of early prostate cancer versus non-conformal techniques: A reduction in acute morbidityInternational Journal of Radiation Oncology*Biology*Physics, 1992
- Tumor Angiogenesis: A New Significant and Independent Prognostic Indicator in Early-Stage Breast CarcinomaJNCI Journal of the National Cancer Institute, 1992
- Staging Laparoscopic Pelvic Lymph Node DissectionArchives of Surgery, 1992
- Serum prostate-specific antigen after post prostatectomy radiotherapyUrology, 1992
- Phase II Radiation Therapy Oncology Group Study of Hormonal Cytoreduction with Flutamide and Zoladex in Locally Advanced Carcinoma of the Prostate Treated with Definitive RadiotherapyAmerican Journal of Clinical Oncology, 1990
- Prostate Specific Antigen in the Diagnosis and Treatment of Adenocarcinoma of the Prostate. II. Radical Prostatectomy Treated PatientsJournal of Urology, 1989
- Pathological Stage is Higher in Older Men with Clinical Stage B1 Adenocarcinoma of the ProstateJournal of Urology, 1989